Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Poznan University of Medical Sciences, Poland.

Professor Jolanta Dorszewska is a distinguished neuroscientist and full professor at the Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poland. With over three decades of research and academic leadership, she has made pioneering contributions to the understanding of neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases. As the head of her department since 2004, she continues to inspire innovation in molecular neurobiology, epigenetics, and neurochemistry.

Profile

Scopus
Orcid

🎓 Education

Prof. Dorszewska’s academic journey began at the Faculty of Pharmacy, Poznan University of Medical Sciences, where she earned her MSc in Pharmacy (1987) with distinction. She continued her academic growth with a PhD (1996) in medical sciences and attained postdoctoral habilitation (2004). She became a Full Professor in 2016, after rigorous training and board certifications in pharmaceutical analytics and medical genetics.

💼 Professional Experience

Her professional path is deeply rooted in neuroscience and pharmacology. She served as an assistant in the Departments of Pharmacy and Clinical Neurochemistry before becoming a Research Associate and later the Head of the Laboratory of Neurobiology. Internationally, she gained experience as a Research Scientist in New York (1999-2000). She has also taught extensively, including at the National High Medical School in Piła.

🔬 Research Interests

Prof. Dorszewska’s research covers a rich spectrum—from analyzing lipid and sterol levels in hypoxia to the genetic and molecular pathways of neurodegeneration. Her work involves advanced techniques like HPLC, ELISA, Western Blot, PCR, and focuses on biomarkers, genetic polymorphisms, miRNAs, and apoptosis in diseases such as Alzheimer’s, Parkinson’s, epilepsy, and migraine. She is especially known for studies on homocysteine metabolism and catecholamine gene mutations.

🏆 Awards & Recognition

She has earned numerous accolades and holds editorial and leadership roles in prestigious journals including Frontiers in Molecular Neuroscience, Journal of Integrative Neuroscience, and Current Alzheimer Research. As a Guest Editor for six major neuroscience journals and a member of international neurological associations, her global contributions to science are widely respected. She was also an Honorary Member of the 12th CONy World Congress (2018).

📚 Selected Publications

🧬 Genetics and Parkinson's Disease

Title: Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson's disease
Journal: IBRO Neuroscience Reports
Date: June 2025
DOI: 10.1016/j.ibneur.2025.01.016
Authors: Jolanta Dorszewska et al.
🔬 Focus: Investigates the role of ZNF746 gene variants and related proteins in the pathophysiology of Parkinson’s disease.

🧠 Neurorehabilitation and Multiple Sclerosis

Title: Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
Journal: Sclerosis
Date: April 3, 2025
DOI: 10.3390/sclerosis3020013
Authors: Katarzyna Wiszniewska et al., including Jolanta Dorszewska
🧘‍♀️ Focus: Explores physical therapy interventions and their molecular impacts in MS patients.

🦠 Parasitic Infections and Proteinopathies

Title: Unraveling the Role of Proteinopathies in Parasitic Infections
Journal: Biomedicines
Date: March 3, 2025
DOI: 10.3390/biomedicines13030610
Authors: Mikołaj Hurła et al., including Jolanta Dorszewska
🧫 Focus: Connects neurodegenerative proteinopathies with parasitic infection mechanisms.

🧪 Neuropharmacology and Aging

Title: Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
Journal: International Journal of Molecular Sciences
Date: February 14, 2025
DOI: 10.3390/ijms26041634
Authors: Małgorzata Anna Lewandowska et al., including Jolanta Dorszewska
🧠 Focus: Studies the impact of Memantine on aging-related neurochemical changes.

🧠 Brain Imaging and Migraine

Title: fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura
Journal: Neurology International
Date: January 21, 2025
DOI: 10.3390/neurolint17020015
Authors: Damian Pikor et al., including Jolanta Dorszewska
🧲 Focus: Uses fMRI to explore visual cortex abnormalities in migraine with aura.

 

 

 

Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

The Ohio State University, United States.

Dr. Jessica L. Fleming, PhD, is an accomplished radiobiologist at the James Comprehensive Cancer Center, The Ohio State University. With over a decade of experience in translational oncology research, she specializes in molecular biomarkers and radiation therapy innovations. Dr. Fleming plays a key role in collaborative clinical and research initiatives, especially in glioma and FLASH radiotherapy. She is also a co-founder and former CEO of the Cap City Biohackers, demonstrating her entrepreneurial edge in biomedical innovation.

Profile

Scopus

🎓 Education

Dr. Fleming earned her PhD in Molecular, Cellular, and Developmental Biology from The Ohio State University in 2012, following a BS in Biology, Cum Laude, from Ashland University in 2006. Her strong academic foundation was supported by multiple fellowships and research opportunities during her undergraduate and graduate studies.

🧪 Experience

Dr. Fleming currently serves as an Associate Radiobiologist at OSU, working with Dr. Arnab Chakravarti. Her journey at OSU began as a graduate student, advancing through postdoctoral research and senior research associate roles. She has led cutting-edge radiobiological studies and was integral to several major clinical protocols. Beyond academia, she was the CEO and Co-Founder of Cap City Biohackers, reflecting her commitment to science outreach and innovation.

🔬 Research Interests

Radiation oncology and molecular oncology, particularly adult gliomas and biomarkers

FLASH radiotherapy, clinical translation, and toxicity modeling

Tumor heterogeneity and resistance mechanisms

Translational research bridging lab discoveries and patient care

🏆 Awards & Honors

🥇 2024 ASTRO Annual Meeting Abstract Award

🏅 Columbus CEO Future 50 Award (2020)

🎖 Best of ASTRO & Basic/Translational Science Abstract Award (2018)

🎓 Alumni Grants for Graduate Research (2012)

🧬 NSF REU Fellow (2005)

🌟 Track & Field Athletic Scholar and Presidential Scholar (2002–2006)

📚 Selected Publications

Here are some of Dr. Fleming’s key publications, with citation and access details:

Fleming JL et al. (2025)Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813Int J Radiat Oncol Biol Phys (Accepted)

Manring HR, Fleming JL et al. (2025)FLASH Radiotherapy: From In Vivo Data to Clinical TranslationHematol Oncol Clin N Am (PMID: 39828472)

Fleming JL, Chakravarti A. (2025)Molecular Biomarkers in Adult Lower-Grade GliomasCancer J, 31(1): e0758. (PMID: 39841423)
Cited by: 2 articles

Kotecha R, Schiff D, Chakravarti A, Fleming JL et al. (2024)Management of IDH-Mutated GliomasJ Clin Oncol, 42(21): 2588-2598. (PMID: 38833641)
Cited by: 15 articles

Becker AP, Becker V, McElroy J, Fleming J et al. (2024)HMGB2 as Biomarker in AstrocytomasCancers (Basel), 16(8): 1516. (PMID: 38672598)
Cited by: 7 articles